London, UK, 13 November 2025 - IMU Biosciences (or "the Company”), a biotechnology company decoding the immune system to drive next generation health outcomes, today announced the formation of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback